Algorithm S.A.L.

When a drug developer loses a partner, there's actually a 50-50 chance that the drug will remain in development, according to a new study of deals data from Informa’s Strategic Transactions . And of

IN VITRO DIAGNOSTICS Mergers & Acquisitions Danaher Corp. Beckman Coulter Inc. Siemens AG Siemens Healthcare Diagnostics Inc. Danaher Corp.’s Beckman Coulter Inc. bought Siemens Healthcare Diagnostics

IN VITRO DIAGNOSTICS Mergers & Acquisitions Grifols SA Novartis AG Novartis Vaccines & Diagnostics Inc. Grifols SA (plasma therapies) acquired the transfusion diagnostics business of Novartis AG